[Adjuvant chemotherapy with Capecitabine as new standard for resected cholangiocarcinomas - a look at the BILCAP trial]

Z Gastroenterol. 2018 Jul;56(7):839-840. doi: 10.1055/s-0044-100936. Epub 2018 Jul 9.
[Article in German]
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Capecitabine* / adverse effects
  • Capecitabine* / therapeutic use
  • Chemotherapy, Adjuvant*
  • Cholangiocarcinoma* / drug therapy
  • Cholangiocarcinoma* / mortality
  • Deoxycytidine
  • Fluorouracil
  • Humans
  • Middle Aged
  • Neoplasm Staging

Substances

  • Deoxycytidine
  • Capecitabine
  • Fluorouracil